Macragol Powder

Nom de l'organisation

Merckle GmbH

SRN

DE-MF-000018230

Statut du fabricant

Actif

11 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW275

  Macrogol can be taken during pregnancy and breast-feeding. Ask your doctor or pharmacist for advice before taking Macrogol
• CW135

  EUDAMED n'a pas publié de description pour ce code.
• CW999

  There is insufficient experience with the use of Macrogol in children. It is therefore not recommended for use in children under 12 years.
• CW277

  You may get diarrhoea, which can cause the body to dehydrate. If this occurs, stop taking Macrogol and drink plenty of fluids. If you experience severe pain, bloating or severe diarrhoea, please contact your doctor.
• CW276

  The effectiveness of some medicines, e.g. antiepileptic agents, may be reduced while taking Macrogol. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
• CW999

  You can take the product at any time you like, with or without food and drink. Always take Macrogol [brand name] exactly as directed in this leaflet. This product must not be taken in undiluted form.
• CW262

  If you forget to take Macrogol, Do not take a double dose. Continue to use at the prescribed dosage.
• CW999

  Sometimes, you may get digestive problems, stomach ache or increased bowel sounds. You may also feel bloated, experience flatulence, nausea or vomiting, anal/rectal irritation and, when you first start taking Macrogol [brand name], mild diarrhoea. These side effects generally improve as soon as the dose of Macrogol [brand name] is reduced. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
• CW008

  In individual cases, hypersensitivity reactions/allergic reactions (skin rash, itching, skin redness, hives), swollen hands, feet or ankles, headache or increased and decreased blood potassium levels may occur. Diarrhoea may occur especially at the start of therapy or if the dosage is too high.
• CW010

  EUDAMED n'a pas publié de description pour ce code.
• CW999

  More prolonged use may be needed for severe chronic or persistent constipation. In this case, please talk to your doctor. Constipation can also occur in diseases such as multiple sclerosis or Parkinson’s disease or can be caused by taking medicines that promote constipation, such as strong painkillers (opioids) or medicines for Parkinson’s disease (anticholinergic agents).

Marché principal en Allemagne ; disponible dans 2 pays au total.

Dénomination commerciale

Macragol Powder

Code d'UDI-DI

D-251267NR

Basic UDI-DI

B-251267NR

Numéro de référence/catalogue

251267

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Also Marketed under catalogue numbers: 251271, 251266, 251268, 251270, 127794, 127795, 127796

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel